- Article
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) Treatment in People Living with HIV: A Single-Center Real-World Experience from Belgrade, Serbia
- Marko Markovic,
- Jovan Ranin,
- Aleksa Despotovic,
- Ivan Rajkovic,
- Jovana Ranin,
- Milan Tanasijevic,
- Nikola Mitrovic,
- Natasa Nikolic,
- Ivana Milosevic and
- Ivana Gmizic
Introduction: Doravirine/lamivudine/tenofovir disoproxil fumarate (DOR/3TC/TDF) is recommended for both ART initiation and switch in virologically suppressed patients. We report early real-world outcomes after DOR/3TC/TDF introduction in Belgrade, Se...

